Molecular mechanisms, current management and next generation therapy in myeloma bone disease.
Heusschen R et al. Leuk Lymphoma. 2017 Jun 2:1-15. doi: 10.1080/10428194.2017.1323272. [Epub ahead of print].

An unusual presentation of multiple myeloma with unilateral sudden vision loss: A case report.
Wu PW et al. Medicine (Baltimore). 2017 Jun;96(25):e7277. doi: 10.1097/MD.0000000000007277.

Metabolic Syndrome in Long-Term Survivors of Hematopoietic Stem-Cell Transplantation.
Ragbourne SC et al. Clin Lymphoma Myeloma Leuk. 2017 Jun;17(6):340-346. doi: 10.1016/j.clml.2017.05.004.

Outcomes of newly diagnosed myeloma patients requiring dialysis: renal recovery, importance of rapid response and survival benefit.
Dimopoulos MA et al. Blood Cancer J. 2017 Jun 16;7(6):e571. doi: 10.1038/bcj.2017.49.

Myeloma patients: genes increase risk for osteonecrosis of the jaw.
Becnel M et al. Leuk Lymphoma. 2017 Jun 14:1-2. doi: 10.1080/10428194.2017.1337116. [Epub ahead of print].

Genetic factors related with early onset of osteonecrosis of the jaw in patients with multiple myeloma under zoledronic acid therapy.
Kastritis E et al. Leuk Lymphoma. 2017 Jun 11:1-6. doi: 10.1080/10428194.2017.1300889. [Epub ahead of print].

Renal impairment and use of nephrotoxic agents in patients with multiple myeloma in the clinical practice setting in the United States.
Qian Y et al. Cancer Med. 2017 Jun 14. doi: 10.1002/cam4.1075. [Epub ahead of print].

Transplantation Related Toxicity and Mortality in Older Autologous Hematopoietic Cell Transplantation Recipients.
Belete H et al. Am J Hematol. 2017 Jun 13. doi: 10.1002/ajh.24814. [Epub ahead of print].

Extradural plasmacytoma with central nervous system involvement in newly diagnosed multiple myeloma.
Kaito S et Int J Hematol. 2017 Jun 12. doi: 10.1007/s12185-017-2277-2. [Epub ahead of print].

Impact of concomitant dexamethasone dosing schedule on bortezomib-induced peripheral neuropathy in multiple myeloma.
Kumar SK et al. Br J Haematol. 2017 Jun 7. doi: 10.1111/bjh.14754. [Epub ahead of print].

Outcomes of Primary Total Knee Arthroplasty in Patients With Hematopoietic Stem Cell Transplantation.
Chalmers BP et al. Orthopedics. 2017 Jun 6:1-5. doi: 10.3928/01477447-20170531-01. [Epub ahead of print].